2020, Governance, Patient Advocacy and Prescription Drug Pricing

In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts

Health Populi

JANUARY 29, 2019

See the dark blue dot in 2023 north of the other dots, representing the median costs for a non-oncology drug with orphan status priced around $300,000. Other key trends to expect leading to 2023 will be: The rise of patient advocacy roles in pharma companies. IQVIA recognizes that, “the (U.S.)

Prescription Drug Pricing

Prescription Drug Pricing FDA Patient Advocacy Governance

Health Care Compliance Brief

In 2023, the U.S. Will Still Be the #1 Prescription Drug Spender in the World, IQVIA Forecasts

Stay Connected